Kaynaklar
1.
Pritchard J, Weisman R, Ratnoff O et al. Intravascular haemolysis,
thrombocytopenia and other haematologic abnormalities associated
with severe toxemia of pregnancy. New England Journal of Medicine
1954;250:89-98.
2.
Sibai BM, Taslimi MM, el-Nazer A et al. Maternal-perinatal outcome
associated with the syndrome of hemolysis, elevated liver enzymes and
low platelets HELLP syndrome. American Journal of Obstetrics and
Gynecology 1993;169:1000-6.
3.
Weinstein L. Preeclampsia/eclampsia with heamolysis, elevated liver
enzymes and thrombocytopenia.
Obstetrics and Gynecology
1985;66:657-60.
4.
Martin JN Jr, Blake PG, Perry KG et al. The natural history of HELLP
syndrome: patterns of disease progressin and regression. American
Journal of Obstetrics and Gynecology 1991;164:1500-9.
5.
Thiagarajah S, Bourgeois FJ, Harbert Gin Jr et al. Thrombocytopenia in
preeclampsia. American Journal
of Obstetrics and Gynecology
1984;150:1-7.
6.
Magann EF, Perry KG, Meyderech EF et al. Postpartum corticosteroids:
accelerated recovery from the syndrome of hemolysis, elevated liver
enzymes and low platelets (HELLP). American Journal of Obstetrics
and Gynecology 1994;171(4):1154-8.
7.
Magann EF, Bass D, Chauhan SP et al. Antepartum corticosteroids: dis-
ease stabilization in patients with the syndrome of hemolysis, elevated
liver enzymes and low platelets (HELLP). American Journal of
Obstetrics and Gynecology 1994;171:1148-53.
8.
Vigil-De Gracia P, Garcia-Caceres E. Dexamethasone in the post-par-
tum treatment of HELLP syndrome. International Journal of Obstetrics
and Gynecology 1997;59:217-21.
9.
Kadanali S, Kucukozkan T, Bukan B. Helpful effect of high-dose cor-
ticosteroid use on Hellp syndrome. Jinekoloji
ve Obstetrik Dergisi
1997;11:55-8.
10. Yalcin OT, Sener T, Hassa H. Effects of postpartum corticosteroids in
patients with HELLP syndrome. International Journal of Obstetrics and
Gynecology 1998;61:141-8.
11. Isler C, Barrilleaux P, Magann E. A prospective, radomized trial com-
paring the eficacy of dexamethasone and betamethasone fort he treat-
ment of antepartum HELLP (hemolysis, elevated liver enzymes and
low platelet count) syndrome. American Journal of Obstetrics and
Gynecology 2001;184(7):1332-7.
12. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in preg-
nancy. Cochrane Database Syst. Review. 2004;(1):CD002076.
13. Cunningham FG, Gant NF, Kenneth JL. Hypertensive disorders in
pregnancy. Williams Obstetrics 21
th
ed. McGraw-Hill; 2001;567-
618.
14. Martin JN Jr, Rinehart B, May WL et al. The spectrum of severe
preeclampsia: Comparative analysis by HELLP syndrome classifica-
tion. Am J Obstet Gynecol 1999;180:1373-84.
15. Sibai BM, Ramadan MK, Usta I. Maternal morbidity and mortality in
442 pregnancies with hemolysis, elevated liver enzymes, and low
platelets. Am J Obstet Gynecol 1993;169:1000-6.
16. Varol F, Aydin T, Gucer F. HELLP syndrome and postpartum corti-
costeroids. Int J Gynecol Obstet 2001;73:157-9.
17. Fonseca J, Mendez F, Catano C. Dexamethasone treatment does not
improve the outcome of women with HELLP syndrome: A double-
blind, placebo-controlled, randomized clinical trial. Am J Obstet
Gynecol 2005;193:1591-8.
18. Mould S, Paruk F, Moodley J. High-dose dexamethasone in the treat-
ment of HELLP syndrome. Int J Gynecol Obstet 2006;93:140-1.
83
J Turkish-German Gynecol Assoc, Vol. 9(2); 2008
J Turkish-German Gynecol Assoc, Vol. 9(2); 2008